Preview

Neurology, Neuropsychiatry, Psychosomatics

Advanced search
Fullscreen

For citation:


Boyko A.N., Spirin N.N., Vlasov Y.V., Zakharova M.N. Current requirements for studies of drugs for the pathogenetic treatment of multiple sclerosis. Neurology, Neuropsychiatry, Psychosomatics. 2019;11(4):166-171. (In Russ.) https://doi.org/10.14412/2074-2711-2019-4-166-171

Views: 142


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2074-2711 (Print)
ISSN 2310-1342 (Online)